Ask AI

Arm-in-Arm With Heart Failure Experts: A Master Class in Optimizing Heart Failure Treatment With SGLT2 Inhibitors

Better understand the current recommendations of guideline-directed medical therapy for patients with heart failure, including the latest data on SGLT2 inhibitors and why these therapies should be started early to achieve improved patient outcomes across the ejection fraction spectrum, through an expert-written ClinicalThought, downloadable slides, and an on-demand webcast.

Share

Program Content

Events

Activities

SGLT2 inhibitors for heart failure
Arm-in-Arm With Heart Failure Experts: A Master Class in Optimizing Heart Failure Treatment With SGLT2 Inhibitors
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 25, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company